Why This Seattle Biotech Could be an M&A Target
Immune Design is a clinical-stage immunotherapy company. Source: BioSpace
Heptares Co-Founder Resigns as VP and CSO of Parent Company Sosei
Dr. Marshall will leave Sosei at the end of February 2018. Source: BioSpace
This Cancer Drug Could Bring in $3.8B for AstraZeneca
The survey of 51 oncologists suggests broad uptake of Imfinzi in advanced lung cancer patients who can't be treated with surgery. Source: BioSpace
Shire's Incoming Financial Head Honcho Finally Gets a Start Date
Shire will have its new CFO in March. Source: BioSpace
Teva's Job Cuts Hit 208 Philadelphia Employees
The cuts are being made as the company grapples with a debt of between $30 and $35B and a restructuring of its R&D in order to combat dramatically declining revenue…
What You Need to Know About Jecure Therapeutics
Jecure Therapeutics, based in San Diego, stated operations in mid-2016 with a focus on NASH and liver fibrosis. Source: BioSpace
Bay Area Biotech Perlara's Rare Strategy for Getting Ahead: Telling the Truth
Perlstein's approach with his start-up, Perlara, is radically different from how most start-ups operate. Source: BioSpace
Little Known Life Science Hedge Fund Dethroning Ackman's Pershing Square
This little-known hedge fund that has a focus on biotech and the life sciences beat out a couple of the heavy-hitters, David Einhorn and Bill Ackman. Source: BioSpace
PTAB Throws Out Janssen Patent for Prostate Cancer Drug
The PTO’s Patent Trial and Appeal Board ruled against a Janssen patent for its prostate cancer drug Zytiga, in another setback for the company in it its efforts to keep…
Senate Bill Would Expand Medication-Assisted Therapy Options
A bipartisan group of senators introduced a bill that would broaden access to medication-assisted therapies for opioid addiction. Source: Drug Industry Daily
- Go to the previous page
- 1
- …
- 193
- 194
- 195
- 196
- 197
- 198
- 199
- …
- 610
- Go to the next page